NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM3538051 Query DataSets for GSM3538051
Status Public on Mar 31, 2019
Title Untreated Set 2
Sample type SRA
 
Source name Control/Untreated
Organism Homo sapiens
Characteristics differentiation status: Differentiated
cell type: Podocytes (Glomerulus cells)
differentiation duration: 14 day differentiation
Treatment protocol Podocytes were incubated 4hours in the serum free RPMI medium and injury was given using PAN (100μg/ml) and Adriamycin (0.25μg/ml) for 48 hours.
Growth protocol RPMI 1640-based medium supplemented with 10% fetal bovine serum (FBS) (Invitrogen), 2 g/liter of sodium bicarbonate (NaHCO3), insulin-transferrin-selenium (ITS) supplement (Sigma-Aldrich), and 200 units/ml penicillin and streptomycin (Roche Applied Science)
Extracted molecule total RNA
Extraction protocol RNA was isolated using the qiagen RNeasy Mini Kit (Cat. No # 74104) and 1 ug of total RNA was used for the construction of sequencing libraries.
RNA libraries were prepared for sequencing using standard Illumina protocols
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model Illumina HiSeq 2500
 
Description Immortalized Human Podocytes Cell Lines
Data processing Downstream bioinformatics analyses was performed by using a combination of programs including Bowtie2, Tophat2, HTseq and Cufflink .
Reference genome and gene model annotation files were acquired from NCBI/UCSC/Ensemble genome browser.
Indexes of the reference genome were built using Bowtie v2.0.6 and paired-end clean reads were aligned to the reference genome using TopHat v2.0.9.
Gene expression level quantification was done using HTSeq v0.6.1 and for each gene read numbers counts were mapped, whereas, Reads Per Kilobase of exon model (RPKM) of each gene was calculated based on the length of the gene and expression levels were analyzed
DESeq2 R package (2_1.6.3) database was used for the differential expression (DE) analyses. The resulting P-values were adjusted using the Benjamini and Hochberg’s approach and adjusted P-value <0.05 found by DESeq2 were assigned as DE. Analyses of DE of two conditions was performed using the DEGSeq R package (1.12.0). The P-values were also adjusted using Benjamini & Hochberg method. Corrected P-value of 0.005 and log2 (Fold change) of 1 were set as threshold for significantly differential expression.
Genome_build: Hg19
Supplementary_files_format_and_content: tab-delimited text files include RPKM values for each Sample.
 
Submission date Jan 03, 2019
Last update date Mar 31, 2019
Contact name Deepak Nihalani
E-mail(s) nihalani@musc.edu
Organization name Medical University of South Carolina
Department Medicine/Nephrology
Lab DDB520
Street address 70 President St.
City Charleston
State/province SC
ZIP/Postal code 29424
Country USA
 
Platform ID GPL16791
Series (1)
GSE124622 Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes
Relations
BioSample SAMN10689641
SRA SRX5202528

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap